Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03855358 |
|---|---|
| Brief Title: | A Study of TQB2450 Injection and Anlotinib Hydrochloride Capsules to Treat Triple Negative Breast Cancer (TNBC) |
| First Submitted : | February 25, 2019 |
| First Submitted that Met QC Criteria : | February 25, 2019 |
| First Posted : | February 26, 2019 |
| Last Update Submitted that Met QC Criteria : | October 29, 2019 |
| Last Update Posted : | October 30, 2019 |